-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WRT+CQd4nb78qluftKg9JjvT4ouBFAAnHVU1AG0AjJx61/E1EDOYZmQf3BNWqJh2 TPLov5jgOIVg44RS50vY5Q== 0000732485-07-000040.txt : 20071115 0000732485-07-000040.hdr.sgml : 20071115 20071115110422 ACCESSION NUMBER: 0000732485-07-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071113 FILED AS OF DATE: 20071115 DATE AS OF CHANGE: 20071115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DZAU VICTOR J CENTRAL INDEX KEY: 0001201252 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 071248261 MAIL ADDRESS: STREET 1: GENZYME CORP STREET 2: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 dza339.xml X0202 4 2007-11-13 0 0000732485 GENZYME CORP GENZ 0001201252 DZAU VICTOR J GENZYME CORPORATION 500 KENDALL STREET CAMBRIDGE MA 02142 1 0 0 0 Genzyme common stock (GENZ) 2007-11-13 4 M 0 1000 58.50 A 1000 D Genzyme common stock (GENZ) 2007-11-13 4 M 0 9000 62.98 A 10000 D Genzyme common stock (GENZ) 2007-11-13 4 S 0 10000 72.00 D 0 D Genzyme DOP NQ Stock Option (right to buy) 58.50 2007-11-13 4 M 0 1000 0 D 2007-05-25 2016-05-26 Genzyme common stock (GENZ) 1000 14000 D Genzyme DOP Stock Option (right to buy) 62.98 2007-11-13 4 M 0 9000 0 D 2006-05-26 2015-05-26 Genzyme common stock (GENZ) 9000 15000 D Options vest 100% on the date of the next annual meeting of shareholders following the original date of grant. By: Susan P. Cogswell, Attorney-in-Fact 2007-11-15 -----END PRIVACY-ENHANCED MESSAGE-----